This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Vertex Pharmaceuticals Inc (VRTX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 1.04B 625.26M 569.30M 489.41M
Receivables 177.64M 90.06M 85.52M 143.25M
Inventories 56.08M 30.85M 14.15M 30.46M
Other Current Assets 0.00 9.01M 0.00 0.00
Total Current Assets 1.36B 1.55B 1.59B 1.59B
Property, Plant & Equipment, Gross 697.72M 994.20M 1.01B 730.29M
Accumulated Depreciation & Depletion n.a. 278.39M 308.33M 296.69M
Property, Plant & Equipment, Net 697.72M 715.81M 696.91M 433.61M
Intangibles 334.72M 29.00M 0.00 663.50M
Other Non-Current Assets 109.51M 3.44M 2.56M 41.60M
Total Non-Current Assets 1.14B 788.17M 730.47M 1.17B
Liabilities & Shareholder Equity
Total Assets 2.50B 2.33B 2.32B 2.76B
Accounts Payable 0.00 83.41M 67.66M 130.30M
Short Term Debt 0.00 32.01M 16.89M 13.71M
Other Current Liabilities 431.94M 14.84M 33.10M 41.53M
Total Current Liabilities 583.75M 368.25M 397.83M 432.62M
Long Term Debt 295.45M 280.57M 0.00 400.00M
Deferred Income Taxes n.a. 15.04M 0.00 280.37M
Other Non-Current Liabilities 473.04M 62.26M 75.12M 167.24M
Minority Interest -31.85M -4.19M -242.52M 55.90M
Total Non-Current Liabilities 820.61M 891.42M 564.81M 1.33B
Total Liabilities 1.40B 1.26B 962.64M 1.76B
Preferred Stock Equity n.a. 0.00 0.00 0.00
Common Stock Equity 1.09B 1.08B 1.36B 999.18M
Common Par n.a. 2.38M 2.32M 2.15M
Additional Paid In Capital 0.00 5.78B 5.32B 4.52B
Cumulative Translation Adjustment n.a. 0.00 0.00 0.00
Retained Earnings 0.00 -4.71B -3.97B -3.52B
Treasury Stock n.a. 0.00 0.00 0.00
Other Equity Adjustments 1.09B 917.00K -306.00K -550.00K
Total Capitalization 1.39B 1.36B 1.36B 1.40B
Total Equity 1.09B 1.08B 1.36B 999.18M
Total Liabilities & Stock Equity 2.50B 2.33B 2.32B 2.76B
Total Common Shares Outstanding 245.72M 241.76M 233.79M 217.29M
Preferred Shares n.a. 0.00 0.00 0.00
Treasury Shares n.a. 0.00 0.00 0.00
Basic Weighted Shares Outstanding 241.31M 235.31M 224.91M 211.95M
Diluted Weighted Shares Outstanding 241.31M 235.31M 224.91M 211.95M
Number of Employees NA 1830 1800 2200
Number of Part-Time Employees NA 0 0 0
VRTX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

VRTX Vertex Pharmaceuticals Inc

Chart of VRTX

Analysts Ratings for VRTX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 9 7 7 7
Moderate Buy 1 1 1 1
Hold 5 7 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET VRTX ANALYST REPORT

VRTX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs